What is the primary objective of post-market surveillance in vaccine safety monitoring?
Question 2
Which of the following best describes the role of an adjuvant in vaccine development?
Question 3
When calculating vaccine coverage, if a target population has $15,000$ individuals and $12,000$ are vaccinated, what is the vaccination coverage percentage?
Question 4
Which of the following is a critical factor in maintaining the efficacy of vaccines during transportation and storage?
Question 5
What is the primary purpose of conducting Phase III clinical trials in vaccine development?
